Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 446

1.

High-dose vitamin D: Without benefit but not without risk.

Reid IR.

J Intern Med. 2018 Sep 19. doi: 10.1111/joim.12836. [Epub ahead of print] No abstract available.

PMID:
30230641
2.

Calcium and vitamin D: To supplement or not?

Reid IR.

Cleve Clin J Med. 2018 Sep;85(9):693-698. doi: 10.3949/ccjm.85a.18026. No abstract available.

3.

Effects of Leptin on the Skeleton.

Reid IR, Baldock PA, Cornish J.

Endocr Rev. 2018 Dec 1;39(6):938-959. doi: 10.1210/er.2017-00226.

PMID:
30184053
4.

Calcium and vitamin D do not prevent fractures in community-dwelling adults.

Reid IR.

BMJ Evid Based Med. 2018 Oct;23(5):185-186. doi: 10.1136/bmjebm-2018-110974. Epub 2018 Jun 21. Review. No abstract available.

PMID:
29930018
5.

Denosumab for glucocorticoid-induced osteoporosis.

Reid IR.

Nat Rev Endocrinol. 2018 Jul;14(7):383-384. doi: 10.1038/s41574-018-0035-z. No abstract available.

PMID:
29849116
6.

25-Hydroxyvitamin D Threshold for the Effects of Vitamin D Supplements on Bone Density: Secondary Analysis of a Randomized Controlled Trial.

Macdonald HM, Reid IR, Gamble GD, Fraser WD, Tang JC, Wood AD.

J Bone Miner Res. 2018 Aug;33(8):1464-1469. doi: 10.1002/jbmr.3442. Epub 2018 Jun 15.

PMID:
29665087
7.

Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates.

Horne AM, Mihov B, Reid IR.

Calcif Tissue Int. 2018 Jul;103(1):55-61. doi: 10.1007/s00223-018-0404-6. Epub 2018 Feb 14.

PMID:
29445836
8.

Vitamin D Effect on Bone Mineral Density and Fractures.

Reid IR.

Endocrinol Metab Clin North Am. 2017 Dec;46(4):935-945. doi: 10.1016/j.ecl.2017.07.005. Epub 2017 Sep 29. Review.

PMID:
29080644
9.

Lack of Evidence that Soluble Urate Directly Influences Bone Remodelling: A Laboratory and Clinical Study.

Dalbeth N, Pool B, Chhana A, Lin JM, Tay ML, Tan P, Callon KE, Naot D, Horne A, Drake J, Gamble GD, Reid IR, Grey A, Stamp LK, Cornish J.

Calcif Tissue Int. 2018 Jan;102(1):73-84. doi: 10.1007/s00223-017-0328-6. Epub 2017 Oct 10.

PMID:
29018897
10.

Calcium and Cardiovascular Disease.

Reid IR, Birstow SM, Bolland MJ.

Endocrinol Metab (Seoul). 2017 Sep;32(3):339-349. doi: 10.3803/EnM.2017.32.3.339. Review.

11.

Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial.

Grey A, Bolland MJ, Horne A, Mihov B, Gamble G, Reid IR.

CMAJ. 2017 Sep 11;189(36):E1130-E1136. doi: 10.1503/cmaj.161207.

12.

Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults substudy of a randomized controlled trial.

Reid IR, Horne AM, Mihov B, Gamble GD, Al-Abuwsi F, Singh M, Taylor L, Fenwick S, Camargo CA, Stewart AW, Scragg R.

J Intern Med. 2017 Nov;282(5):452-460. doi: 10.1111/joim.12651. Epub 2017 Jul 26.

PMID:
28692172
13.

Are more trials of calcium supplements really needed?

Bolland MJ, Grey A, Reid IR.

Osteoporos Int. 2017 Sep;28(9):2729-2730. doi: 10.1007/s00198-017-3988-1. Epub 2017 Jul 7. No abstract available.

PMID:
28687861
14.

Dietary calcium intake and rate of bone loss in men.

Bristow SM, Gamble GD, Horne AM, Reid IR.

Br J Nutr. 2017 May;117(10):1432-1438. doi: 10.1017/S0007114517001301. Epub 2017 Jun 13.

PMID:
28606219
15.

Targeting Sclerostin in Postmenopausal Osteoporosis: Focus on Romosozumab and Blosozumab.

Reid IR.

BioDrugs. 2017 Aug;31(4):289-297. doi: 10.1007/s40259-017-0229-2. Review.

PMID:
28547661
16.

Serum phosphate is related to adiposity in healthy adults.

Billington EO, Gamble GD, Bristow S, Reid IR.

Eur J Clin Invest. 2017 Jul;47(7):486-493. doi: 10.1111/eci.12769. Epub 2017 Jun 13.

PMID:
28517037
17.

Bone Loss After Denosumab: Only Partial Protection with Zoledronate.

Reid IR, Horne AM, Mihov B, Gamble GD.

Calcif Tissue Int. 2017 Oct;101(4):371-374. doi: 10.1007/s00223-017-0288-x. Epub 2017 May 13.

PMID:
28500448
18.

Calcium Intake and Cardiovascular Disease Risk.

Reid IR, Avenell A, Grey A, Bolland MJ.

Ann Intern Med. 2017 May 2;166(9):684-685. doi: 10.7326/L17-0135. No abstract available.

PMID:
28460389
19.

Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone.

Reid IR, Maslowski K.

Calcif Tissue Int. 2017 Jul;101(1):43-49. doi: 10.1007/s00223-017-0261-8. Epub 2017 Mar 21.

PMID:
28324123
20.

Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.

Billington EO, Horne A, Gamble GD, Maslowski K, House M, Reid IR.

Osteoporos Int. 2017 Jun;28(6):1867-1874. doi: 10.1007/s00198-017-3960-0. Epub 2017 Feb 23.

PMID:
28233020

Supplemental Content

Loading ...
Support Center